Rituximab for the management of idiopathic membranous nephropathy: a meta-analysis
Crossref DOI link: https://doi.org/10.1007/s11255-020-02633-5
Published Online: 2020-09-17
Published Print: 2021-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Lan
Dong, Qiao-Rong
Zhao, Ya-Juan
Hu, Gui-Cai
Text and Data Mining valid from 2020-09-17
Version of Record valid from 2020-09-17
Article History
Received: 26 May 2020
Accepted: 31 August 2020
First Online: 17 September 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.